Glutathione S-transferases and esterases in placenta after normal and pre-eclamptic pregnancies

被引:5
作者
Saldívar, MDT
Juárez, FJ
Viramontes, JL
Vázquez, MLR
del Río, FAP
机构
[1] CINVESTAV, IPN, Secc Externa Farmacol, Mexico City 07000, DF, Mexico
[2] Univ Autonoma Aguascalientes, Ctr Ciencias Basicas, Dept Fisiol & Farmacol, Aquascalientes 20100, Ags, Mexico
关键词
D O I
10.1016/j.placenta.2002.12.001
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Severe pre-eclampsia reduced significantly (P<0.05) by 68 +/- 6 per cent (mean +/-SEM, n=10) the maximal velocity (V-max) and, consequently, reduced significantly by 60 +/- 7 per cent the catalytic efficiency (C-E) of placental glutathione transferase pi, assayed with ethacrynic acid. Mild and severe pre-eclampsia reduced significantly by 82 +/- 5 per cent (mean +/-SEM, n=5) and by 41 +/- 5 per cent (mean +/-SEM, n= 10), respectively, the V-max and, consequently, reduced significantly by 72 +/- 7 and by 33 +/- 13 per cent, respectively, the CE of esterase, assayed with p-nitrophenyl acetate. Furthermore, severe pre-eclampsia increased significantly by 296 +/- 78 per cent the Michaelis-Menten constant (K-m) of total GST, assayed with chlorodinitrobenzene and, consequently, decreased significantly the C-E by 83 +/- 3 per cent. On the other hand, the concentrations of total and non-protein thiols did not change significantly in placental homogenates from patients with mild or severe pre-eclampsia compared to normal pregnancies. These findings would indicate a decreased capacity of the glutathione transferases and esterase detoxification systems to protect the fetus from drugs prescribed to pregnant women suffering pre-eclampsia, mainly in the severe phase. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 47 条
[1]  
AHOKAS JT, 1984, BIOCHEM PHARMACOL, V33, P1629
[2]   IN-VITRO APPROACHES CAN PREDICT HUMAN DRUG-METABOLISM [J].
BIRKETT, DJ ;
MACKENZIE, PI ;
VERONESE, ME ;
MINERS, JO .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (08) :292-294
[3]  
BOYLAND E, 1969, ADV ENZYMOL RELAT AR, V32, P172
[4]   THE PHYSIOLOGY OF PREECLAMPSIA [J].
BROWN, MA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (11) :781-791
[5]  
Chesley LC, 1978, Hypertensive disorders in pregnancy
[6]   KINETIC PARAMETERS OF DRUG-METABOLIZING ENZYMES IN CA2+ - SEDIMENTED MICROSOMES FROM RAT-LIVER [J].
CINTI, DL ;
SCHENKMAN, JB ;
MOLDEUS, P .
BIOCHEMICAL PHARMACOLOGY, 1972, 21 (24) :3249-+
[7]  
CLIFTON G, 1977, CANCER RES, V37, P788
[8]   GLUTATHIONE-PEROXIDASE, GLUTATHIONE-REDUCTASE, GLUTATHIONE S-TRANSFERASE, AND GAMMA-GLUTAMYLTRASPEPTIDASE ACTIVITIES IN THE HUMAN EARLY-PREGNANCY PLACENTA [J].
DIILIO, C ;
POLIDORO, G ;
ARDUINI, A ;
MUCCINI, A ;
FEDERICI, G .
BIOCHEMICAL MEDICINE, 1983, 29 (02) :143-148
[9]   GLUTATHIONE S-TRANSFERASE (TRANSFERASE-PI) FROM HUMAN-PLACENTA IS IDENTICAL OR CLOSELY RELATED TO GLUTATHIONE S-TRANSFERASE (TRANSFERASE-RHO) FROM ERYTHROCYTES [J].
GUTHENBERG, C ;
MANNERVIK, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 661 (02) :255-260
[10]  
HABIG WH, 1974, J BIOL CHEM, V249, P7130